| PLX4720 |
ENSG00000117242.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000117242.7 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000117242.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000124835.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000124915.6 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000152487.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000153363.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000170161.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000171889.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000171889.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000172250.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000175611.7 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000175773.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000177112.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000177133.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000177337.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000177410.8 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000177640.11 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000177757.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000177757.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000177788.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000179219.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000179743.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000180279.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000180422.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000181800.5 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000182366.5 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000184324.11 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000185186.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000185495.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000186019.10 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000186019.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000186148.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000187621.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000187979.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000196668.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000196696.8 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000196951.6 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000196972.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000197210.7 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000197463.8 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000203279.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000203321.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000203327.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000203362.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000203362.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000203441.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000203441.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000203875.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000204011.4 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000204241.3 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000204362.5 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000204791.4 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000204792.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000204832.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000204929.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000205041.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000205444.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000205662.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000205663.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000205663.5 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000205885.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000206140.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000206195.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000206195.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000206337.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000206417.4 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000212163.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000212978.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000213971.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000214146.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000214353.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000214559.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000214691.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000214770.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000214772.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000214851.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000214870.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000215039.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000215068.3 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000215241.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000215374.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000215386.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000215394.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000215394.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000215417.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000215424.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000215483.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000215692.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000215808.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000217258.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000222041.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000222041.6 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000222043.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000222044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000223390.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000223477.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000223478.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000223482.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000223573.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000223576.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000223598.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000223642.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000223652.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000223685.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000223685.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000223695.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000223745.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000223745.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000223768.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000223791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000223804.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000223804.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000223815.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000223842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000223842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000223935.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000223935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000223975.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000223975.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000223979.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000224046.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000224046.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000224057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000224078.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000224081.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000224189.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000224189.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000224260.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000224271.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000224356.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000224376.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000224376.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000224505.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000224596.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000224621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000224623.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000224652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000224660.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000224687.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000224789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000224799.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000224805.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000224805.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000224812.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000224817.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000224818.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000224818.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000224888.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000224897.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000224897.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000224897.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000224899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000224939.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000224950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000225083.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000225173.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000225187.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000225210.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000225213.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000225298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000225335.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000225353.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000225376.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000225377.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000225383.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000225484.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000225490.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000225541.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000225555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000225555.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000225725.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000225744.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000225761.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000225793.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000225822.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000225822.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000225836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000225891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000225914.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000225953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000225981.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000225986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000226047.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000226047.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000226053.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000226091.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000226125.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000226155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000226207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000226245.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000226276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000226291.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000226330.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000226332.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000226332.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000226562.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000226609.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000226648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000226699.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000226756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000226756.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000226782.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000226800.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000226824.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000226846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000226883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000226889.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000226913.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000226920.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000226957.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000226963.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000227036.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000227060.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000227071.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000227110.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000227117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000227155.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000227197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000227197.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000227210.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000227210.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000227245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000227359.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000227403.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000227477.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000227477.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000227486.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000227492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000227496.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000227512.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000227617.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000227702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000227917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000227925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000227959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000228010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000228044.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000228063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000228065.6 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000228084.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000228172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000228223.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000228223.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000228274.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000228288.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000228288.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000228293.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000228294.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000228327.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000228350.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000228397.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000228404.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000228412.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000228444.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000228544.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000228544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000228554.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000228577.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000228614.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000228624.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000228661.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000228748.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000228775.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000228779.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000228786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000228794.4 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000228812.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000228812.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000228817.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000228857.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000228906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000228917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000228989.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000229017.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000229021.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000229043.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000229109.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000229152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000229153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000229178.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000229227.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000229228.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000229267.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000229267.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000229291.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000229388.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000229404.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000229444.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000229444.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000229463.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000229512.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000229536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000229558.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000229697.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000229750.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000229771.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000229801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000229852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000229852.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000229915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000229952.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000229964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000229967.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000229983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000229983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000229999.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000230002.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000230010.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000230061.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000230131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000230140.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000230140.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000230148.4 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000230186.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000230427.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000230439.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000230530.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000230555.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000230606.6 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000230612.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000230628.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000230844.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000230914.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000231023.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000231081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000231104.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000231113.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000231125.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000231128.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000231131.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000231170.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000231185.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000231212.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000231242.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000231298.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000231346.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000231407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000231473.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000231530.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000231663.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000231704.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000231721.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000231728.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000231760.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000231768.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000231794.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000231865.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000231877.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000231903.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000231908.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000232002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000232023.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000232043.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000232053.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000232093.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000232093.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000232116.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000232118.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000232124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000232151.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000232162.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000232274.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000232295.3 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000232336.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000232342.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000232545.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000232642.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000232656.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000232677.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000232686.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000232686.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000232693.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000232725.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000232739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000232756.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000232907.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000232936.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000233016.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000233058.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000233080.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000233144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000233184.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000233203.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000233242.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000233246.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000233339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000233461.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000233461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000233483.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000233515.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000233532.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000233554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000233611.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000233611.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000233621.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000233621.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000233654.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000233672.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000233694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000233705.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000233757.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000233775.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000233783.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000233817.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000233847.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000233885.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000233893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000233930.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000234006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000234006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000234006.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000234019.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000234076.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000234134.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000234139.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000234141.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000234147.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000234161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000234171.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000234199.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000234222.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000234225.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000234327.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000234350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000234428.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000234449.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000234459.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000234478.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000234494.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000234630.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000234676.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000234684.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000234693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000234705.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000234705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000234753.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000234772.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000234817.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000234832.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000235021.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000235027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000235049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000235052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000235078.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000235111.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000235138.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000235172.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000235214.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000235236.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000235257.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000235298.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000235298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000235303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000235314.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000235314.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000235397.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000235453.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000235477.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000235493.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000235545.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000235545.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000235565.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000235586.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000235609.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000235663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000235664.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000235703.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000235703.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000235724.4 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000235781.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000235786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000235831.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000235848.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000235872.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000235954.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000236003.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000236021.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000236051.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000236066.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000236088.5 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000236130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000236137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000236137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000236166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000236194.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000236204.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000236206.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000236209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000236226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000236299.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000236305.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000236333.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000236366.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000236390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000236426.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000236453.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000236499.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000236510.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000236514.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000236537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000236540.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000236545.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000236558.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000236618.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000236671.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000236682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000236753.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000236753.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000236810.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000236861.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000236861.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000236936.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000236943.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000236990.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000237015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000237015.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000237036.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000237073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000237149.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000237149.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000237208.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000237250.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000237250.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000237291.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000237298.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000237310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000237343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000237352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000237357.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000237380.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000237424.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000237424.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000237453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000237489.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000237502.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000237502.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000237512.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000237543.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000237588.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000237594.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000237605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000237737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000237803.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000237883.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000237886.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000237899.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000237998.3 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000238009.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000238018.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000238039.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000238058.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000238140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000238142.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000238198.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000239002.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000239335.4 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000239480.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000239523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000239523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000239945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000240005.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000240050.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000240207.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000240401.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000240453.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000240476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000240549.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000240591.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000240708.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000240710.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000240770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000240770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000240770.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000240790.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000240859.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000240859.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000240915.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000240990.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000241288.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000241288.3 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000241479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000241481.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000241544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000241593.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000241596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000241599.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000241732.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000241769.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000241770.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000241933.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000242048.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000242154.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000242396.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000242396.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000242474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000242553.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000242753.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000242798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000243008.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000243176.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000243230.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000243415.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000243433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000243491.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000243701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000243701.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000243797.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000243926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000243926.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000244040.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000244124.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000244184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000244198.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000244203.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000244252.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000244306.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000244345.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000244349.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000244479.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000244586.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000244757.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000244757.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000244791.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000244879.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000244952.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000245059.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000245080.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000245213.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000245498.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000245552.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000245552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000245711.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000246016.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000246089.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000246130.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000246130.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000246174.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000246323.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000246331.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000246394.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000246560.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000246640.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000246695.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000246695.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000246740.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000246863.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000246982.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000246982.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000247081.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000247081.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000247131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000247137.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000247213.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000247240.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000247317.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000247324.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000247400.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000247498.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000247516.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000247675.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000247675.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000247699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000247735.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000247809.3 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000247828.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000247828.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000247934.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000248092.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000248125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000248161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000248161.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000248243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000248245.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000248254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000248275.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000248367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000248456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000248468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000248473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000248538.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000248576.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000248719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000248773.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000248925.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000248936.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000249042.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000249234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000249234.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000249304.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000249304.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000249328.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000249348.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000249395.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000249412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000249476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000249492.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000249494.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000249572.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000249650.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000249684.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000249685.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000249685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000249734.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000249738.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000249786.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000249923.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000249942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000249955.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000250061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000250073.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000250107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000250116.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000250155.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000250365.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000250410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000250413.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000250447.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000250602.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000250614.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000250682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000250714.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000250748.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000250748.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000250909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000250910.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000250910.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000250934.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000250958.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000250988.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000250990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000251022.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000251093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000251127.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000251164.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000251175.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000251179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000251273.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000251301.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000251307.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000251330.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000251387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000251405.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000251556.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000251562.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000251580.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000251602.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000251666.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000253197.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000253263.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000253266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000253355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000253372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000253395.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000253404.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000253508.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000253535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000253552.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000253562.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000253653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000253696.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000253741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000253741.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000253773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000253829.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000253829.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000253837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000253837.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000253848.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000253875.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000253875.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000253898.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000254099.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000254144.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000254154.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000254177.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000254180.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000254208.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000254238.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000254263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000254315.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000254317.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000254389.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000254414.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000254419.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000254419.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000254451.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000254484.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000254484.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000254484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000254495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000254539.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000254554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000254554.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000254560.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000254631.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000254632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000254648.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000254675.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000254756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000254814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000254833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000254842.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000254842.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000254859.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000254862.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000254878.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000254879.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000254900.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000254973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000254991.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000254991.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000255029.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000255052.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000255089.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000255121.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000255121.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000255139.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000255142.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000255142.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000255153.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000255153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000255158.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000255159.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000255201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000255237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000255250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000255276.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000255299.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000255306.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000255310.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000255318.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000255320.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000255322.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000255337.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000255355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000255395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000255418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000255471.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000255480.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000255557.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000255651.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000255843.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000255866.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000255867.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000255966.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000256083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000256083.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000256084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000256092.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000256128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000256146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000256237.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000256249.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000256250.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000256268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000256325.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000256417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000256433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000256433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000256452.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000256482.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000256482.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000256690.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000256705.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000256789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000256789.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000256862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000256915.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000256940.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000257004.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000257027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000257084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000257135.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000257167.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000257221.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000257258.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000257279.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000257283.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000257284.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000257298.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000257433.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000257488.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000257496.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000257497.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000257497.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000257534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000257543.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000257613.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000257621.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000257711.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000257718.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000257808.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000257831.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000257900.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000257924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000257947.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000257999.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000258096.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000258096.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000258136.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000258171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000258172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000258181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000258279.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000258346.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000258355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000258410.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000258441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000258450.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000258451.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000258454.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000258479.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000258479.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000258534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000258616.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000258623.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000258649.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000258657.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000258658.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000258658.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000258682.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000258701.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000258711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000258730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000258731.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000258815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000258821.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000258825.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000258843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000258860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000258903.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000258919.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000258922.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000258938.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000258957.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000258959.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000259005.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000259062.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000259065.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000259065.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000259070.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000259093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000259116.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000259116.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000259116.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000259118.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000259153.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000259153.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000259153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000259187.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000259201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000259264.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000259287.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000259336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000259343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000259347.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000259364.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000259398.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000259416.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000259418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000259424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000259426.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000259426.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000259426.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000259442.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000259453.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000259469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000259474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000259475.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000259504.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000259504.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000259542.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000259548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000259561.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000259583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000259584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000259595.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000259628.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000259635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000259635.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000259635.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000259659.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000259687.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000259705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000259715.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000259760.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000259768.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000259774.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000259775.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000259775.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000259797.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000259826.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000259883.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000259884.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000259901.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000259915.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000259994.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000260006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260032.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260052.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000260063.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000260065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000260065.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000260132.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000260141.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000260176.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000260185.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000260252.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260261.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260281.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000260285.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000260293.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000260293.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000260360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000260360.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000260360.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000260388.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000260411.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000260418.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000260425.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000260436.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000260439.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000260448.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000260475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000260493.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000260495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000260515.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000260528.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260583.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260588.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000260612.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000260616.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000260630.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000260661.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000260664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000260708.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000260743.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000260744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000260750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000260750.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000260774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000260803.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000260841.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000260877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000260891.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000260911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000260920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000260923.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000260923.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000260927.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000260953.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000260954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000260955.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000260971.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000260974.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000260988.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000260989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261005.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000261005.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000261008.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000261024.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000261080.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000261124.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000261131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261168.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000261173.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000261183.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000261189.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261200.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000261212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000261254.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000261286.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000261291.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000261291.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261298.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000261302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261324.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261329.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261355.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261360.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000261360.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261372.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000261428.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000261438.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000261442.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000261451.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000261468.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000261471.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000261481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000261496.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000261521.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261533.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000261533.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000261533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261574.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000261589.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000261646.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261671.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000261692.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261697.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000261723.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000261744.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000261783.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000261801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000261801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000261824.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261827.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000261839.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000261864.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000261879.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000261886.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000261888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000261889.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000261924.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000262001.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000262038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000262089.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000262117.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000262117.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000262312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000262339.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000262380.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000262454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000262668.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000262692.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000262810.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000262833.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000262888.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000262888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000262888.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000262951.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000262951.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000262952.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000263013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000263050.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000263069.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000263164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000263167.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000263182.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000263300.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000263325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000263338.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000263350.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000263388.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000263388.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000263470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000263612.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000263644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000263680.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000263745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000263745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000263786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000263884.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000263893.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000263916.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000263923.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000263931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000263931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000264007.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000264235.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000264247.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000264260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000264270.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000264569.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000264595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000264630.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000264630.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000264745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000264808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000264812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000264853.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000264876.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000264940.2 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000264964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000265008.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000265008.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000265334.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000265342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000265413.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000265445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000265451.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000265478.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000265556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000265692.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000265778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000265778.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000265801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000265845.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000266100.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000266176.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000266176.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000266304.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000266445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000266473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000266473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000266521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000266598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000266651.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000266783.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000266801.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000266805.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000266821.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000266824.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000266835.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000266844.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000266904.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000266921.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000266933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000266934.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000266942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000266968.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000266976.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000267003.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000267006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000267010.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000267010.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000267040.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000267053.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000267093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000267151.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000267213.3 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000267219.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000267221.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000267221.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000267222.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000267249.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000267254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000267289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000267304.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000267374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000267412.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000267414.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000267449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000267454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000267457.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000267501.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000267504.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000267530.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000267581.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000267583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000267583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000267588.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000267605.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000267655.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000267677.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000267705.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000267715.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000267715.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000267747.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000267766.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000267787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000267898.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000267905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000267939.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000267940.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000268061.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000268189.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000268201.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000268204.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000268230.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000268230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000268231.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000268366.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000268458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000268460.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000268516.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000268544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000268583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000268583.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000268601.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000268621.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000268650.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000268743.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000268746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000268764.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000268764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000268895.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000268895.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000268938.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000269038.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000269051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000269107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000269191.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000269191.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000269386.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000269425.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000269480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000269481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000269600.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000269707.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000269814.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000269815.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000269873.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000269893.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000269894.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000269898.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000269899.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000269901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000269906.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000269918.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000269919.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000269923.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000269924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000269925.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000269942.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000269959.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000269974.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000269983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000269990.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000269997.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000270001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000270006.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000270010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000270015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000270019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000270039.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000270049.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000270050.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000270067.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000270068.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000270068.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000270074.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000270103.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000270109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000270116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000270116.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000270133.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000270145.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000270178.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000270265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000270362.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000270362.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000270419.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000270605.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000270605.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000270673.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000270742.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000270755.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000270949.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000270964.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000271065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000271151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000271151.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000271156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000271199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000271308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000271367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000271384.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000271398.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000271398.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000271538.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000271554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000271555.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000271576.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000271722.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000271738.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000271766.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000271811.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000271821.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000271826.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000271833.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000271855.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000271857.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000271862.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000271882.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000271888.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000271889.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000271913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000271913.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000271914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000271914.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000271926.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000271927.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000271930.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000271971.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000271973.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000271975.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000271993.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000271998.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272005.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000272021.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000272065.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000272070.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000272076.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000272077.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272086.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000272088.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272094.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000272112.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000272129.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000272137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272142.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000272146.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000272158.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000272183.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000272205.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000272221.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000272221.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000272226.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000272275.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000272301.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000272316.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000272327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272335.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000272374.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000272386.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000272425.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000272430.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272432.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272438.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000272452.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272457.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000272459.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272483.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000272489.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000272520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000272520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272525.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272525.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000272556.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000272558.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000272562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000272563.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000272604.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000272620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000272622.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000272630.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000272646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000272662.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272663.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000272667.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000272667.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272669.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000272691.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000272692.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272692.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000272692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000272702.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272716.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272734.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000272755.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272755.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000272764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000272784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000272792.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000272795.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000272800.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000272828.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000272829.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000272834.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000272859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000272870.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272872.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000272885.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000272888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272894.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000272911.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000272917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000272933.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000272940.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000272960.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272979.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000272983.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000272995.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000272995.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000273001.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000273004.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000273004.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000273008.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000273009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000273014.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000273017.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000273027.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000273032.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000273033.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000273035.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000273061.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000273065.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000273076.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000273076.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000273139.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000273139.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PLX4720 |
ENSG00000273145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000273153.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000273176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
ENSG00000273179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000273198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000273203.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000273237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000273245.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PLX4720 |
ENSG00000273245.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000273247.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000273248.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000273249.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000273267.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000273270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000273281.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000273297.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PLX4720 |
ENSG00000273305.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000273305.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PLX4720 |
ENSG00000273307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PLX4720 |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000273319.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PLX4720 |
ENSG00000273338.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PLX4720 |
ENSG00000273341.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000273353.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000273355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000273365.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000273381.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PLX4720 |
ENSG00000273384.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PLX4720 |
ENSG00000273384.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000273416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PLX4720 |
ENSG00000273448.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PLX4720 |
ENSG00000273472.1 |
Predicted lncRNA |
Sarcoma |
|
| PLX4720 |
ENSG00000273487.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PLX4720 |
let-7a |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
let-7b |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
let-7c |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
let-7e |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-100 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-128 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-1287 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-1291 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-1293 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-1301 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-132 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-146a |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-155 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-184 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-185 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-192 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-200c |
Curated miRNA |
melanoma |
|
| PLX4720 |
miR-21 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-2277 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-23a |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-23b |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-24-2 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-27a |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-27b |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-30b |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-30d |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-3187 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-3200 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-320a |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-328 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-331 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-335 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-340 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-3607 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-361 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-363 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-3651 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-3653 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-3917 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-409 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-424 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-425 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-4467 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-4473 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-449c |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-4664 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-4745 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-490 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-503 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-504 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-543 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-584 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-660 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-664a |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-7 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-760 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-769 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-92a-1 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-96 |
Curated miRNA |
thyroid cancer |
|
| PLX4720 |
miR-99a |
Curated miRNA |
thyroid cancer |
|
